Detalhe da pesquisa
1.
Is HLA type a possible cancer risk modifier in Lynch syndrome?
Int J Cancer
; 152(10): 2024-2031, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214792
2.
Recurrent Frameshift Neoantigen Vaccine Elicits Protective Immunity With Reduced Tumor Burden and Improved Overall Survival in a Lynch Syndrome Mouse Model.
Gastroenterology
; 161(4): 1288-1302.e13, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224739
3.
Vaccines for immunoprevention of DNA mismatch repair deficient cancers.
J Immunother Cancer
; 10(6)2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732349
4.
NMD inhibition by 5-azacytidine augments presentation of immunogenic frameshift-derived neoepitopes.
iScience
; 24(4): 102389, 2021 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33981976
5.
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution.
Nat Commun
; 11(1): 4740, 2020 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32958755